Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The postprandial acid pocket is a distinct layer of unbuffered, highly acidic gastric juice that accumulates in the proximal stomach near the gastroesophageal junction after meal ingestion [1]. While the bulk of the meal buffers the rest of the stomach's contents, this "pocket" remains at a low pH (typically <2.0) and serves as the primary reservoir for acid that refluxes into the esophagus [2]. It usually forms within 15 to 30 minutes post-meal and is particularly prominent in patients with hiatal hernias or gastroesophageal reflux disease (GERD) [3]. Therapeutic intervention often involves the use of alginates, which form a physical "raft" that sits atop the gastric contents to neutralize or physically block the acid pocket from entering the esophagus [4]. Other treatments include proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs), which aim to reduce the overall volume and acidity of the pocket [5]. Monitoring the position and pH of this pocket is essential for understanding the pathophysiology of breakthrough reflux symptoms [6]. Citations: [1] Fletcher J, et al. (2001) Gastroenterology 121(3):505-514. [2] Beaumont H, et al. (2010) Gut 59(4):441-451. [3] Kwiatek MA, et al. (2011) Aliment Pharmacol Ther 33(5):534-541. [4] Rohof WO, et al. (2013) Clin Gastroenterol Hepatol 11(12):1585-1591. [5] Woodland P, et al. (2014) Am J Gastroenterol 109(9):1331-1340. [6] Pandolfino JE, et al. (2007) Gastroenterology 132(2):507-517.
Alginate-based medications react with gastric acid to form a low-density pH-neutral gel raft that floats on top of the gastric contents, specifically targeting the postprandial acid pocket by physically displacing it away from the gastroesophageal junction or sequestering it within the gel matrix [4]. This physical barrier prevents the acidic pocket from refluxing into the esophagus during transient lower esophageal sphincter relaxations (TLESRs). Additionally, antacids neutralize the acid within the pocket, while proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) reduce the secretion of the hydrochloric acid that constitutes the pocket [5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Postprandial acid pocket (Acid pocket) (Acid pocket).